Literature DB >> 18456766

Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

J Bellmunt1, S Albiol, V Kataja.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18456766     DOI： 10.1093/annonc/mdn085

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

1.  First- and second-line therapy for metastatic urothelial carcinoma of the bladder.

Authors:  F A Yafi; S North; W Kassouf
Journal:  Curr Oncol       Date:  2011-01       Impact factor: 3.677

2.  Quality of care in bladder cancer: trends in urinary diversion following radical cystectomy.

Authors:  John L Gore; Mark S Litwin
Journal:  World J Urol       Date:  2008-11-20       Impact factor: 4.226

3.  Clinical significance and prognostic value of S100A4 and matrix metalloproteinase-14 in patients with organ-confined bladder cancer.

Authors:  Yuji Sagara; Yasuyoshi Miyata; Takahisa Iwata; Shigeru Kanda; Tomayoshi Hayashi; Hideki Sakai; Hiroshi Kanetake
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

4.  Risk groups in bladder cancer patients treated with radical cystectomy.

Authors:  Eva Mallen; Pedro Gil; Maria Jesus Gil
Journal:  Int Braz J Urol       Date:  2015 Jan-Feb       Impact factor: 1.541
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.